Dx Dialogues: Cutaneous Melanoma

Featured Content

• 

  Article

  Integrating clinical trials into melanoma care: Identification, timing, and referral strategies

  Strategic patient identification and timing optimize access to emerging therapies

• 

  Article

  Cellular immunotherapy in advanced melanoma: Expanding treatment options beyond checkpoint inhibition

  Autologous TIL therapy demonstrates durable responses in checkpoint-refractory disease

• 

  Article

  TCR engineered T cells: Targeting intracellular tumor antigens in melanoma

  PRAME-directed approaches access intracellular proteins through HLA presentation